Document is current
Any future updates will be listed below
-
Authors
Wang, Ping
Zhou, Jingyu
Gao, Haokao
Hu, Tao
Sun, Dongdong
Wang, Qiong
Jiang, Hong
Yin, Zhiyong
Wen, Shangyu
Jin, Yuanzhe
Chen, Hui
Yuan, Ming
Zhong, Lin
Hu, Sigan
Lian, Zhexun
Jiang, Zhiwei
Xia, Jielai
Liu, Jianzheng
Fu, Guotao
He, Xingqiang
Zhu, Bin
Garg, Scot
Onuma, Yoshinobu
Wang, Duolao
Serruys, Patrick W.
Gao, Chao
Tao, Ling
-
Funding
Funding for this research was provided by:
Xijing Hospital (XJZT24LY36)
- License Information
-
More Information
Article History
Received: 24 July 2025
Accepted: 16 January 2026
First Online: 22 January 2026
Declarations
:
: All participants included in the REC-CAGEFREE I provided informed consent for the data and samples to be used for scientific purposes. The study was conducted in accordance with the Declaration of Helsinki and was approved by the relevant Ethics Committees of all participating centers. The central ethics approval reference number is KY20202070-C-1.
: Not applicable.
: PWS reports consulting fees from Sahajanand Medical Technologies, Novartis, and Merillife. SG reports consulting fees from Biosensors. ZJia is the founder of Beijing KeyTech Statistical Consulting and has stock in the company. All other authors declare no competing interests.
